Revelation Capital Management, LLC — Q4 2025 13F-HR

← Revelation Capital Management, LLC

Q4 2025 · 13F-HR

Revelation Capital Management, LLCholdings as filed

Filed 2026-02-17 · accession 0001104659-26-015812

$83.5M

Reported value

Positions

2025-12-31

Period end

View analyzed profile →PRO

The Brief · Revelation Capital Management, LLC · Q4 2025

AI · grounded in 13F

Revelation Capital Management, LLC established a new position in OMDA valued at $82.18M. The fund also added ARTV with a new position of $1.28M. To fund these moves, the firm closed positions in SINGULAR GENOMICS SYSTEMS INC, AKILI INC, and NPCE.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
68170A108	OMDA	OMADA HEALTH INC	$82.2M	98.5%	5,208,034	Common	SOLE
04317A107	ARTV	ARTIVA BIOTHERAPEUTICS INC	$1.3M	1.54%	299,311	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.